Molecular Spectroscopy Market

Molecular spectroscopy sales will grow through 2036, led by mass spectroscopy at a 36.9% share. Pharmaceuticals lead with a 38.9% share, driven by stringent quality control requirements in drug development. The market is set to reach USD 7.8 billion by 2026-end and USD 15.1 billion by 2036, creating an incremental opportunity of USD 7.25 billion.